Yuancheng Chen Selected Research

contezolid

1/2022	Clinical Pharmacology and Utility of Contezolid in Chinese Patients with Complicated Skin and Soft-Tissue Infections.
10/2021	Pharmacokinetics and Disposition of Contezolid in Humans: Resolution of a Disproportionate Human Metabolite for Clinical Development.
1/2020	Evaluation of the Effect of Contezolid (MRX-I) on the Corrected QT Interval in a Randomized, Double-Blind, Placebo- and Positive-Controlled Crossover Study in Healthy Chinese Volunteers.
1/2019	Tolerability and Pharmacokinetics of Contezolid at Therapeutic and Supratherapeutic Doses in Healthy Chinese Subjects, and Assessment of Contezolid Dosing Regimens Based on Pharmacokinetic/Pharmacodynamic Analysis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Yuancheng Chen Research Topics

Disease

14	Infections 06/2022 - 01/2016
3	Respiratory Tract Infections (Respiratory Tract Infection) 05/2022 - 03/2016
3	Healthcare-Associated Pneumonia 05/2022 - 01/2016
3	Body Weight (Weight, Body) 05/2022 - 11/2020
2	Sepsis (Septicemia) 02/2022 - 01/2021
2	Soft Tissue Infections 01/2022 - 01/2020
2	Pneumonia (Pneumonitis) 01/2021 - 01/2019
2	Gram-Positive Bacterial Infections 01/2021 - 01/2017
2	Meningitis 02/2017 - 11/2016
2	Neoplasms (Cancer) 08/2012 - 01/2012
1	Ventilator-Associated Pneumonia 05/2022
1	Ankylosing Spondylitis 05/2022
1	Gram-Negative Bacterial Infections 01/2021
1	Invasive Candidiasis 12/2020
1	Spontaneous Abortion (Miscarriage) 11/2020
1	Renal Insufficiency (Renal Failure) 11/2020
1	Familial Dysalbuminemic Hyperthyroxinemia 11/2020
1	Hyperthyroxinemia 11/2020
1	Epilepsy (Aura) 07/2019
1	Staphylococcal Infections 01/2017
1	Inflammation (Inflammations) 01/2013
1	Disease Progression 01/2013
1	Neutropenia 08/2012
1	Breast Neoplasms (Breast Cancer) 01/2012

Drug/Important Bio-Agent (IBA)

6	Pharmaceutical PreparationsIBA 05/2022 - 01/2012
4	contezolidIBA 01/2022 - 01/2019
4	Anti-Bacterial Agents (Antibiotics)IBA 10/2021 - 03/2016
3	Carbapenems (Carbapenem Antibiotics)IBA 06/2022 - 01/2019
3	Polymyxin B (Aerosporin)FDA LinkGeneric 02/2022 - 01/2021
3	Oxazolidinones (2 Oxazolidone)IBA 10/2021 - 01/2019
3	Vancomycin FDA LinkGeneric 01/2021 - 11/2018
3	Meropenem (Merrem)FDA LinkGeneric 01/2019 - 11/2016
2	Colistin (Coly-Mycin)FDA Link 06/2022 - 01/2019
2	Sulbactam FDA LinkGeneric 05/2022 - 01/2016
2	Cefoperazone (Cefoperazone Sodium)FDA Link 05/2022 - 01/2016
2	Biosimilar PharmaceuticalsIBA 05/2022 - 12/2020
2	Polymyxins (Polymyxin)IBA 02/2022 - 01/2021
2	AlbuminsIBA 01/2022 - 11/2020
2	QuinolonesIBA 01/2021 - 01/2019
2	nemonoxacinIBA 01/2021 - 01/2019
1	methanesulfonic acid (methanesulfonate)IBA 06/2022
1	LactamsIBA 05/2022
1	Adalimumab (Humira)FDA Link 05/2022
1	CreatinineIBA 05/2022
1	Minocycline (Cyclops)FDA LinkGeneric 02/2022
1	TabletsIBA 01/2022
1	Amphotericin B (Amphotericin)FDA LinkGeneric 12/2020
1	Thyrotropin (Thyroid-Stimulating Hormone)FDA Link 11/2020
1	Triiodothyronine (Liothyronine)FDA LinkGeneric 11/2020
1	Levofloxacin (Levaquin)FDA Link 07/2020
1	Anti-Infective Agents (Microbicides)IBA 07/2020
1	DP-VPAIBA 07/2019
1	Valproic Acid (Depakote)FDA LinkGeneric 07/2019
1	Phospholipids (Phosphatides)FDA LinkGeneric 07/2019
1	ProdrugsIBA 07/2019
1	CoagulaseIBA 11/2018
1	levornidazoleIBA 01/2018
1	Linezolid (Zyvox)FDA Link 01/2017
1	biapenem (L 627)IBA 03/2016
1	LipopolysaccharidesIBA 01/2013
1	CytokinesIBA 01/2013
1	Azithromycin (Zithromax)FDA LinkGeneric 01/2013
1	Gemcitabine FDA Link 08/2012
1	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2012

Therapy/Procedure

5	Therapeutics 05/2022 - 01/2016
2	Oral Administration 01/2020 - 01/2019
1	Drug Therapy (Chemotherapy) 08/2012